Prescribing changes for nicotine vaping products
29 Sep 2021
The Therapeutic Goods Administration (TGA) has announced that consumers will require a prescription for all purchases of nicotine vaping products from Australia and overseas from 1 October 2021. This includes nicotine e-cigarettes, nicotine pods and liquid nicotine.
If considered the most clinically appropriate approach for smoking cessation, medical practitioners have three pathways to prescribe nicotine-containing products:
- Become an ‘Authorised Prescriber’ under the Authorised Prescriber Scheme.
- Obtain approval under the Special Access Scheme.
-
Provide a prescription under the Personal Importation Scheme.
To facilitate nicotine and smoking cessation counselling services, the Government has introduced 18 new temporary Medicare Benefits Schedule items for face-to-face, telehealth and phone consultations. The temporary items will be in place until 30 June 2022 and allow Medicare benefits to be paid for telehealth health care services relating to nicotine and smoking cessation counselling without the requirement for the patient to have an established clinical relationship with the GP.
Further information:
- NPS Prescribing changes for nicotine vaping products
- RACGP Supporting smoking cessation: A guide for health professionals (to be updated shortly with new guidance re nicotine vaping products)
Not yet subscribed to receive our medico-legal blog? Scroll down to subscribe and stay connected.
This blog contains general information only. We recommend you contact your medical defence organisation or insurer when you require specific advice in relation to medico-legal matters.
Doctors Let's Talk: Get Yourself A Fricking GP
Get yourself a fricking GP stat! is a conversation with Dr Lam, 2019 RACGP National General Practitioner of the Year, rural GP and GP Anesthetics trainee, that explores the importance of finding your own GP as a Junior Doctor.
25 Oct 2022
Systematic efforts to reduce harms due to prescribed opioids – webinar recording
Efforts are underway across the healthcare system to reduce harms caused by pharmaceutical opioids. This 43-min recording of a live webinar, delivered 11 March 2021, is an opportunity for prescribers to check, and potentially improve, their contribution to these endeavours. Hear from an expert panel about recent opioid reforms by the Therapeutic Goods Administration and changes to the Pharmaceutical Benefits Scheme.
14 May 2021
Diplomacy in a hierarchy: tips for approaching a difficult conversation
Have you found yourself wondering how to broach a tough topic of conversation? It can be challenging to effectively navigate a disagreement with a co-worker, especially if they're 'above' you; however, it's vital for positive team dynamics and safe patient care. In this recording of a live webinar you'll have the opportunity to learn from colleagues' experiences around difficult discussions and hear from a diverse panel moderated by Dr Kiely Kim (medico-legal adviser and general practitioner). Recorded live on 2 September 2020.
05 Oct 2020
